122 related articles for article (PubMed ID: 20484171)
1. Significant sirolimus and dronedarone interaction in a kidney transplant recipient.
Tichy EM; Medwid AJ; Mills EA; Formica RN; Kulkarni S
Ann Pharmacother; 2010; 44(7-8):1338-41. PubMed ID: 20484171
[TBL] [Abstract][Full Text] [Related]
2. Elevated international normalized ratio associated with use of dronedarone and warfarin.
Pogge EK; Haber SL
Ann Pharmacother; 2011 Sep; 45(9):e46. PubMed ID: 21811004
[TBL] [Abstract][Full Text] [Related]
3. Amiodarone-sirolimus/tacrolimus interaction in a pediatric heart transplant patient.
Nalli N; Stewart-Teixeira L; Dipchand AI
Pediatr Transplant; 2006 Sep; 10(6):736-9. PubMed ID: 16911499
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic interaction between everolimus and antifungal triazoles in a liver transplant patient.
Pea F; Baccarani U; Tavio M; Cojutti P; Adani GL; Londero A; Baraldo M; Franceschi L; Furlanut M; Viale P
Ann Pharmacother; 2008 Nov; 42(11):1711-6. PubMed ID: 18812562
[TBL] [Abstract][Full Text] [Related]
5. Dronedarone-induced digoxin toxicity: new drug, new interactions.
Vallakati A; Chandra PA; Pednekar M; Frankel R; Shani J
Am J Ther; 2013; 20(6):e717-9. PubMed ID: 21519214
[TBL] [Abstract][Full Text] [Related]
6. Cyclosporine and sirolimus pharmacokinetics and drug-to-drug interactions in kidney transplant recipients.
Felipe CR; Park SI; Pinheiro-Machado PG; Garcia R; Casarini DE; Moreira S; Tedesco-Silva H; Medina-Pestana JO
Fundam Clin Pharmacol; 2009 Oct; 23(5):625-31. PubMed ID: 19656203
[TBL] [Abstract][Full Text] [Related]
7. Dronedarone: an amiodarone analog for the treatment of atrial fibrillation and atrial flutter.
Dale KM; White CM
Ann Pharmacother; 2007 Apr; 41(4):599-605. PubMed ID: 17389667
[TBL] [Abstract][Full Text] [Related]
8. Dronedarone: an alternative to amiodarone?
Hughes PJ; Freeman MK; Cohenour FV; Price EM
Consult Pharm; 2010 Sep; 25(9):555-69. PubMed ID: 20876046
[TBL] [Abstract][Full Text] [Related]
9. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
Dösch AO; Ehlermann P; Koch A; Remppis A; Katus HA; Dengler TJ
Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172
[TBL] [Abstract][Full Text] [Related]
10. Dronedarone: a review of characteristics and clinical data.
Baroletti S; Catella J; Ehle M; Cheng JW
Crit Pathw Cardiol; 2010 Jun; 9(2):94-101. PubMed ID: 20520217
[TBL] [Abstract][Full Text] [Related]
11. Immunosuppressive drug monitoring of sirolimus and cyclosporine in pediatric patients.
Oellerich M; Armstrong VW; Streit F; Weber L; Tönshoff B
Clin Biochem; 2004 Jun; 37(6):424-8. PubMed ID: 15183289
[TBL] [Abstract][Full Text] [Related]
12. Effect of coadministered HIV-protease inhibitors on tacrolimus and sirolimus blood concentrations in a kidney transplant recipient.
Barau C; Blouin P; Creput C; Taburet AM; Durrbach A; Furlan V
Fundam Clin Pharmacol; 2009 Aug; 23(4):423-5. PubMed ID: 19709321
[TBL] [Abstract][Full Text] [Related]
13. Significant tacrolimus and dronedarone interaction in a kidney transplant recipient.
Marin-Casino M; Pérez-Sáez MJ; Crespo M; Echeverría D; Mir M; Pascual J
Transplantation; 2014 Aug; 98(4):e33-4. PubMed ID: 25243519
[No Abstract] [Full Text] [Related]
14. Longitudinal assessment of everolimus in de novo renal transplant recipients over the first post-transplant year: pharmacokinetics, exposure-response relationships, and influence on cyclosporine.
Kovarik JM; Kahan BD; Kaplan B; Lorber M; Winkler M; Rouilly M; Gerbeau C; Cambon N; Boger R; Rordorf C;
Clin Pharmacol Ther; 2001 Jan; 69(1):48-56. PubMed ID: 11180038
[TBL] [Abstract][Full Text] [Related]
15. Dronedarone: a novel antiarrhythmic agent for the treatment of atrial fibrillation.
Duray GZ; Ehrlich JR; Hohnloser SH
Curr Opin Cardiol; 2010 Jan; 25(1):53-8. PubMed ID: 19881340
[TBL] [Abstract][Full Text] [Related]
16. Limited sampling strategies for the estimation of sirolimus daily exposure in kidney transplant recipients on a calcineurin inhibitor-free regimen.
Cattaneo D; Cortinovis M; Baldelli S; Gotti E; Remuzzi G; Perico N
J Clin Pharmacol; 2009 Jul; 49(7):773-81. PubMed ID: 19491334
[TBL] [Abstract][Full Text] [Related]
17. [Dronedarone--a new therapeutic option for controlling atrial rhythm and ventricular frequency].
Klein HH
Dtsch Med Wochenschr; 2006 Aug; 131(34-35 Suppl 4):S113-7. PubMed ID: 16921447
[No Abstract] [Full Text] [Related]
18. Interaction between everolimus and tacrolimus in renal transplant recipients: a pharmacokinetic controlled trial.
Pascual J; del Castillo D; Cabello M; Pallardó L; Grinyó JM; Fernández AM; Brunet M
Transplantation; 2010 Apr; 89(8):994-1000. PubMed ID: 20335831
[TBL] [Abstract][Full Text] [Related]
19. Thymoglobulin, sirolimus, and reduced-dose cyclosporine provides excellent rejection prophylaxis for pancreas transplantation.
Knight RJ; Kerman RH; Zela S; Podder H; Van Buren CT; Katz S; Kahan BD
Transplantation; 2003 Apr; 75(8):1301-6. PubMed ID: 12717220
[TBL] [Abstract][Full Text] [Related]
20. Dronedarone: an emerging therapy for atrial fibrillation.
Rosei EA; Salvetti M
Ther Adv Cardiovasc Dis; 2010 Jun; 4(3):155-64. PubMed ID: 20418270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]